High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 11, 2008, Pages 4367-4372

  Ye, Lei ^a   Santarpia, Libero ^a   Cote, Gilbert J ^a   El Naggar, Adel K ^a   Gagel, Robert F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN RET;

ALLELE; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 19P; CHROMOSOME 7Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE CLUSTER; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

EID: 57349167652     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0912     Document Type: Article

References (18)

1. Drosten M, Pützer BM 2006 Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nat Clin Pract Oncol 3:564-574
2. Messina M, Robinson BG 2007 Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab 3:290-301
3. Cranston AN, Ponder BA 2003 Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model. Cancer Res 63:4777-4780
4. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN1991 Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699
5. Mulligan LM, Gardner E, Smith BA, Mathew CG, Ponder BA 1993 Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer 6:166-177
6. Huang SC, Koch CA, Vortmeyer AO, Pack SD, Lichtenauer UD, Mannan P, Lubensky IA, Chrousos GP, Gagel RF, Pacak K, Zhuang Z 2000 Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res 60: 6223-6226
7. Koch CA, Brouwers FM, Vortmeyer AO, Tannapfel A, Libutti SK, Zhuang Z, Pacak K, Neumann HP, Paschke R 2006 Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma. BMC Cancer 6:131
8. Koch CA, Huang SC, Moley JF, Azumi N, Chrousos GP, Gagel RF, Zhuang Z, Pacak K, Vortmeyer AO 2001 Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma. Oncogene 20:7809-7811
9. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H 1999 DNA copy number changes in thyroid carcinoma. Am J Pathol 154:1539-1547
10. Frisk T, Zedenius J, Lundberg J, Wallin G, Kytola S, Larsson C 2001 CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. Int J Oncol 18:1219-1225
11. Marsh DJ, Theodosopoulos G, Martin-Schulte K, Richardson AL, Philips J, Röher HD, Delbridge L, Robinson BG 2003 Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 88:1866-1872
12. van Veelen W, van Gasteren CJ, Acton DS, Franklin DS, Berger R, Lips CJ, Höppener J 2008 Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development. Cancer Res 68:1329-1337
13. Wang DG, Liu WH, Johnston CF, Sloan JM, Buchanan KD 1998 Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis. Am J Pathol 152:1407-1413
14. Coxon AB, Ward JM, Geradts J, Otterson GA, Zajac-Kaye M, Kaye FJ 1998 RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene 17:1625-1628
15. Hinze R, Gimm O, Taubert H, Bauer G, Dralle H, Holzhausen HJ, Rath FW 2000 Regulation of proliferation and apoptosis in sporadic and hereditary medullary thyroid carcinomas and their putative precursor lesions. Virchows Arch 437:256-263
16. Mise N, Drosten M, Racek T, Tannapfel A, Pützer BM 2006 Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. Oncogene 25:6637-6647
17. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM 1999 Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18:4948-4957
18. Kushner BH, Cheung NK 2008 Neuroblastoma - linking a common allele to a rare disease. N Engl J Med 358:2585-2593